Characterization of a cross-reactive, immunodominant and HLA-promiscuous epitope of Mycobacterium tuberculosis-specific major antigenic protein PPE68

PLoS ONE

Volumn 9, Issue 8, 2014, Pages

  Mustafa, Abu S ^a  

^a KUWAIT UNIVERSITY   (Kuwait)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; BCG VACCINE; EPITOPE; GAMMA INTERFERON; HLA ANTIGEN; HLA DR ANTIGEN; PEPTIDE DERIVATIVE; PEPTIDE P9; PROTEIN PPE68; UNCLASSIFIED DRUG; BACTERIAL ANTIGEN; PPE68 PROTEIN, MYCOBACTERIUM TUBERCULOSIS;

ANTIGEN BINDING; ARTICLE; BACTERIAL STRAIN; CONTROLLED STUDY; CYTOKINE RELEASE; HLA TYPING; HUMAN; HUMAN CELL; IN VITRO STUDY; LYMPHOID CELL LINE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PREDICTION; PROTEIN ANALYSIS; T LYMPHOCYTE; TH1 CELL; AMINO ACID SEQUENCE; BINDING SITE; BIOSYNTHESIS; CHEMISTRY; CROSS REACTION; GENETICS; IMMUNOLOGY; METABOLISM; MICROBIOLOGY; MOLECULAR GENETICS; MYCOBACTERIUM AVIUM COMPLEX; MYCOBACTERIUM LEPRAE; NUCLEOTIDE SEQUENCE; PEPTIDE MAPPING; PRIMARY CELL CULTURE; SEQUENCE ALIGNMENT; TUBERCULOSIS, PULMONARY; VACCINATION;

AMINO ACID SEQUENCE; ANTIGENS, BACTERIAL; BACTERIAL PROTEINS; BCG VACCINE; BINDING SITES; CONSERVED SEQUENCE; CROSS REACTIONS; EPITOPES, T-LYMPHOCYTE; HLA-DR ANTIGENS; HUMANS; INTERFERON-GAMMA; MOLECULAR SEQUENCE DATA; MYCOBACTERIUM AVIUM COMPLEX; MYCOBACTERIUM LEPRAE; MYCOBACTERIUM TUBERCULOSIS; PEPTIDE MAPPING; PRIMARY CELL CULTURE; SEQUENCE ALIGNMENT; TH1 CELLS; TUBERCULOSIS, PULMONARY; VACCINATION;

EID: 84940276607     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0103679     Document Type: Article

References (50)

1. World Health Organization (2010) Global Tuberculosis Control. WHO Report 2010, WHO/HTM/TB/2010.7.
2. Lönnroth K, Raviglione M (2008) Global epidemiology of tuberculosis: prospects for control. Semin Respir Crit Care Med 29: 481-491.
3. Al-Attiyah R, Mustafa AS, Abal AT, Madi NM, Andersen P (2003) Restoration of mycobacterial antigen-induced proliferation and interferon-gamma responses in peripheral blood mononuclear cells of tuberculosis patients upon effective chemotherapy. FEMS Immunol Med Microbiol 38: 249-256.
4. Demissie A, Abebe M, Aseffa A, Rook G, Fletcher H, et al. (2004) Healthy individuals that control a latent infection with Mycobacterium tuberculosis express high levels of Th1 cytokines and the IL-4 antagonist IL-4delta2. J Immunol 172: 6938-6943.
5. Walzl G, Ronacher K, Hanekom W, Scriba TJ, Zumla A (2011) Immunological biomarkers of tuberculosis. Nat Rev Immunol 11: 343-354.
6. Caccamo N, Barera A, Di Sano C, Meraviglia S, Ivanyi J, et al. (2003) Cytokine profile, HLA restriction and TCR sequence analysis of human CD4+ T clones specific for an immunodominant epitope of Mycobacterium tuberculosis 16-kDa protein. Clin Exp Immunol 133: 260-266.
7. Mustafa AS (2000) HLA-restricted immune response to mycobacterial antigens: relevance to vaccine design. Human Immunol 61: 166-171.
8. Mustafa AS (2009) HLA-promiscuous Th1-cell reactivity of MPT64 (Rv1980c), a major secreted antigen of Mycobacterium tuberculosis, in healthy subjects. Med Princ Pract 18: 385-392.
9. Mustafa AS (2009) Vaccine potential of Mycobacterium tuberculosis- specific genomic regions: in vitro studies in humans. Expert Rev Vaccines 8: 1309-1312.
10. Gordon SV, Brosch R, Billault A, Garnier T, Eiglmeier K, et al. (1999) Identification of variable regions in the genomes of tubercle bacilli using bacterial artificial chromosome arrays. Mol Microbiol 32: 643-655.
11. Mustafa AS (2001) Biotechnology in the development of new vaccines and diagnostic reagents against tuberculosis. Curr Pharm Biotechnol 2: 157-173.
12. Lalvani A, Nagvenkar P, Udwadia Z, Pathan A A, Wilkinson K A, et al. (2001) Enumeration of T cells specific for RD1-encoded antigens suggests a high prevalence of latent Mycobacterium tuberculosis infection in healthy urban Indians. J Infect Dis 183: 469-477.
13. Ravn P, Munk M E, Andersen A B, Lundgren B, Lundgren J D, et al. (2005) Prospective evaluation of a whole-blood test using Mycobacterium tuberculosis-specific antigens ESAT-6 and CFP-10 for diagnosis of active tuberculosis. Clin Diagn Lab Immunol 12: 491-496.
14. Amoudy HA, Al-Turab MB, Mustafa AS (2006) Identification of transcriptionally active open reading frames within the RD1 genomic segment of Mycobacterium tuberculosis. Med Princ Pract 15: 137-144.
15. Mustafa AS, Al-Attiyah R, Hanif SNM, Shaban FA (2008) Efficient testing of pools of large numbers of peptides covering 12 open reading frames of M. tuberculosis RD1 and identification of major antigens and immunodominant peptides recognized by humanTh1 cells. Clin Vaccine Immunol 15: 916-924.
16. Mustafa AS, El-Shamy AM, Madi NM, Amoudy HA, Al-Attiyah R (2008) Cell-mediated immune responses to complex and single mycobacterial antigens in tuberculosis patients with diabetes. Med Princ Pract 17: 325-330.
17. Al-Attiyah R, Mustafa AS (2008) Characterization of human cellular immune responses to novel Mycobacterium tuberculosis antigens encoded by genomic regions absent in Mycobacterium bovis BCG. Infect Immun 76: 4190-4198.
18. Al-Khodari NY, Al-Attiyah R, Mustafa AS (2011) Identification, diagnostic potential, and natural expression of immunodominant seroreactive peptides encoded by five Mycobacterium tuberculosis -specific genomic regions. Clin Vaccine Immunol 18: 477-482.
19. Mustafa AS, Al-Saidi F, El-Shamy AS, Al-Attiyah R (2011) Cytokines in response to proteins predicted in genomic regions of difference of Mycobacterium tuberculosis. Microbiol Immunol 55: 267-278.
20. Mustafa AS, Shaban FA (2006) Propred analysis and experimental evaluation of promiscuous Th1 cell epitopes of three major secreted antigens of Mycobacterium tuberculosis. Tuberculosis (Edinb) 86: 115-124.
21. Al-Attiyah R, Mustafa AS (2010) Characterization of human cellular immune responses to Mycobacterium tuberculosis proteins encoded by genes predicted in RD15 genomic region that is absent in Mycobacterium bovis BCG. FEMS Immunol Med Microbiol 59: 177-187.
22. Al-Attiyah RJ, Mustafa AS (2009) Mycobacterial antigen-induced T helper type 1 (Th1) and Th2 reactivity of peripheral blood mononuclear cells from diabetic and non-diabetic tuberculosis patients and Mycobacterium bovis bacilli Calmette-Guérin (BCG)-vaccinated healthy subjects. Clin Exp Immunol 158: 64-73.
23. Mustafa AS, Oftung F, Amoudy HA, Madi NM, Abal AT, et al. (2000) Multiple epitopes from the Mycobacterium tuberculosis ESAT-6 antigen are recognized by antigen-specific human T cell lines. Clin Infect Dis 30 Suppl 3: S201-S205.
24. Mustafa AS, Abal AT, Shaban F, El-Shamy AM, Amoudy HA (2005) HLA-DR binding prediction and experimental evaluation of mycolyltransferase (Ag85B), a major secreted antigen of Mycobacterium tuberculosis. Med Princ Pract 14: 140-146.
25. Mustafa AS, Shaban FA, Al-Attiyah R, Abal AT, El-Shamy AM, et al. (2003) Human Th1 cell lines recognize the Mycobacterium tuberculosis ESAT-6 antigen and its peptides in association with frequently expressed HLA class II molecules. Scand J Immunol 57: 125-134.
26. Mustafa AS, Oftung F (1993) Long-lasting T-cell reactivity to Mycobacterium leprae antigens in human volunteers vaccinated with killed M. leprae. Vaccine 11: 1108-1112.
27. Singh H, Raghava GPS (2001) ProPred: Prediction of HLA-DR binding sites. Bioinformatics 17: 1236-1237.
28. Al-Attiyah R, Mustafa AS (2004) Computer-assisted prediction of HLA-DR binding and experimental analysis for human promiscuous Th1 cell peptides in a novel 24-kDa secreted lipoprotein (LppX) of Mycobacterium tuberculosis. Scand J Immunol 59: 16-24.
29. Mustafa AS (2009) Th1-cell reactivity and HLA-DR binding prediction for promiscuous recognition of MPT63 (Rv1926c), a major secreted protein of Mycobacterium tuberculosis. Scand J Immunol 69: 213-222.
30. Mustafa AS (2010) In silico binding predictions for identification of HLA-DR-promiscuous regions and epitopes of Mycobacterium tuberculosis protein MPT64 (Rv1980c), and their recognition by human Th1 cells. Med Princ Pract 19: 367-372.
31. Nielsen M, Lund O (2009) NN-align. An artificial neural network-based alignment algorithm for MHC class II peptide binding prediction. BMC Bioinformatics 10: 296.
32. Wang P, Sidney J, Dow C, Mothé B, Sette A, et al. (2008) A systematic assessment of MHC class II peptide binding predictions and evaluation of a consensus approach. PLoS Comput Biol 4:e1000048.
33. Gupta SK, Srivastava M, Akhoon BA, Smita S, Schmitz U, et al. (2011) Identification of immunogenic consensus T-cell epitopes in globally distributed influenza-A H1N1 neuraminidase. Infect Genet Evol 11: 308-319.
34. Okkels LM, Brock I, Follmann F, Aager EM, Arend SM, et al. (2003) PPE protein (Rv3873) from DNA segment RD1 of Mycobacterium tuberculosis: strong recognition of both specific T-cell epitopes and epitopes conserved within the PPE family. Infect Immun 71: 6116-6123.
35. Mustafa AS (1988) Identification of T-cell-activating recombinant antigens shared among three candidate antileprosy vaccines, killed M. leprae, M. bovis BCG, and mycobacterium w. Int J Lepr Other Mycobact Dis 56: 265-273.
36. Dheda K, van Zyl Smit R, Badri M, Pai M (2009). T-cell interferon-gamma release assays for the rapid immunodiagnosis of tuberculosis: clinical utility in high-burden vs. low-burden settings. Curr Opin Pulm Med 15: 188-200.
37. Storla DG, Kristiansen I, Oftung F, Korsvold GE, Gaupset M, et al. (2009) Use of interferon gamma-based assay to diagnose tuberculosis infection in health care workers after short term exposure. BMC Infect Dis 9: 60.
38. Mustafa AS (2010) Cell mediated immunity assays identify proteins of diagnostic and vaccine potential from genomic regions of difference of Mycobacterium tuberculosis. Kuwait Med J 42: 98-105.
39. Mustafa AS (2011) Comparative evaluation of MPT83 (Rv2873) for T helper-1 cell reactivity and identification of HLA-promiscuous peptides: studies in M. bovis BCG-vaccinated healthy subjects. Clin Vaccine Immunol 18: 1752-1759.
40. Al-Attiyah R, Shaban FA, Wiker HG, Oftung F, Mustafa AS (2003) Synthetic peptides identify promiscuous human Th1 cell epitopes of the secreted mycobacterial antigen MPB70. Infect Immun 71: 1953-1960.
41. Aoshi T, Nagata T, Suzuki M, Uchijima M, Hashimoto D, et al. (2008) Identification of an HLA-A*0201-restricted T-cell epitope on the MPT51 protein, a major secreted protein derived from Mycobacterium tuberculosis, by MPT51 overlapping peptide screening. Infect Immun 76: 1565-1571.
42. Launois P, DeLeys R, Niang MN, Drowart A, Andrien M, et al. (1994) T-cell-epitope mapping of the major secreted mycobacterial antigen Ag85A in tuberculosis and leprosy. Infect Immun 62: 3679-3687.
43. Oftung F, Mustafa AS, Shinnick TM, Houghten RA, Kvalheim G, et al. (1988) Epitopes of the Mycobacterium tuberculosis 65-kilodalton protein antigen as recognized by human T cells. J Immunol 141: 2749-2754.
44. Silver RF, Wallis RS, Ellner JJ (1995) Mapping of T cell epitopes of the 30-kDa alpha antigen of Mycobacterium bovis strain bacillus Calmette- Guérin in purified protein derivative (PPD)-positive individuals. J Immunol 154: 4665-4674.
45. Dimitrov I, Garnev P, Flower DR, Doytchinova I (2010) MHC Class II Binding Prediction-A Little Help from a Friend. J Biomed Biotechnol 2010: 705821.
46. Nielsen M, Justesen S, Lund O, Lundegaard C, Buus S (2010) NetMHCIIpan-2.0 - Improved pan-specific HLA-DR predictions using a novel concurrent alignment and weight optimization training procedure. Immunome Res 13;6:9.
47. Bhasin M, Raghava GPS (2007) A hybrid approach for predicting promiscuous MHC class I restricted T cell epitopes. J Biosci 32: 31-42.
48. Singh H, Raghava GPS (2003). ProPred1: Prediction of promiscuous MHC class-I binding sites. Bioinformatics 19: 1009-1014.
49. Du G, Chen CY, Shen Y, Qiu L, Huang D et al. (2010) TCR repertoire, clonal dominance, and pulmonary trafficking of mycobacterium-specific CD4+ and CD8+ T effector cells in immunity against tuberculosis. J Immunol 185: 3940-3947.
50. Bruns H, Meinken C, Schauenberg P, Härter G, Kern P, et al. (2009) Anti-TNF immunotherapy reduces CD8+ T cell-mediated antimicrobial activity against Mycobacterium tuberculosis in humans. J Clin Invest 119: 1167-1177.